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1. Introduction
  Infectious disease is one of the leading causes of death 
worldwide, particularly, in developing countries. The 
treatment of most of the infectious diseases depends 
on the use of antibiotics or antimicrobial drugs. Global 
antimicrobial resistance is becoming an increasing 
public health predicament. Bacteria resistant to almost 
all available antibiotics have been identified[1]. Multiply 
resistant organisms render therapy more precarious and 
costly and sometimes unsuccessful. In developing countries, 
multidrug resistant enteric disease agents such as Vibrio 
cholerae (V. cholerae), Escherichia coli (E. coli) and Shigella 
spps. threaten and circumvent public health measures.
  Diarrhoeal diseases are a major public health apprehension 
in Bangladesh. Every year a large number of people suffer 
from diarrhoea. V. cholerae is the major causative agent of 
cholera, the devastating diarrhoeal disease. In Bangladesh, 
V. cholerae O1 has developed antimicrobial resistance 
to trimethoprim, sulfamethoxazole, furazolidone and 
tetracyclin; and resistance is emerging to ciprofloxacin and 
azithromycin leaving few options for effective antimicrobial 
treatment for cholera[2,3]. Multidrug resistant V. cholerae 
have also emerged in African countries[4,5]. Besides, other 
enteric pathogens, including Shigella spp, diarrhoeagenic 
E. coli, and Salmonella spp., are rapidly growing resistance 
to currently available antibiotics[6]. Therefore, it is an urgent 
need to discover and develop more effective and new 
antimicrobial agents. 
  Natural products from the medicinal plants, spices 
Objective: To investigate in vitro and in vivo antibacterial potentials of Vitex negundo (V. 
negundo) leaf extracts against diverse enteric pathogens. Methods: Water and methanol extracts 
of V. negundo leaves were evaluated against enteric bacterial pathogens by using standard 
disc diffusion, viable bacterial cell count methods, determination of minimum inhibitory 
concentrations (MIC) and minimum bactericidal concentrations (MBC). Results: Methanol extract 
of V. negundo leaves showed potent antibacterial activity (inhibition zone: 9.9-22.6 mm, MIC: 
200-3 200 毺g/mL, MBC: 200-6 400 毺g/mL) against all the pathogenic enteric bacteria (Vibrio 
cholerae, Vibrio parahaemolyticus, Vibrio mimicus, Echerichia coli, Shigella spps., and Aeromonas 
spps) tested. Methanol extract of V. negundo leaves showed potent bactericidal activity both in 
vitro laboratory conditions (MBC, 200-400 毺g/mL) and in the intestinal environment (Dose, 1-2 
mg/mL) of infant mice against pathogenic Vibrio cholerae, the major causative agent of cholera. 
Furthermore, assays using the mice cholera model showed that V. negundo methanol extract can 
protect mice from Vibrio cholerae infection and significantly decrease the mortality rate (P<0.0001). 
Conclusions: For the first time we showed that methanol extract of V. negundo leaves exhibited 
strong vibriocidal activity both in vitro and in vivo conditions. Therefore, it will be useful to 
identify and isolate the active compounds of this extract that could be a good alternative of 
antibiotics to treat cholera.  
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and herbs were used worldwide and their antimicrobial 
potential has been recognized since antiquity[7]. A large 
number of modern medicines were derived originally from 
ancient herbal traditions. Medicinal plants have been 
used as remedies for human diseases for many years as 
they contain components of therapeutic value. There are 
numerous natural plant products which have antimicrobial 
activities that could be used either systemically or locally[8]. 
Antimicrobials of plant origin are effective in the treatment 
of infectious diseases while simultaneously mitigating 
many of the side effects that are often associated with 
synthetic antimicrobials[9]. Therefore, natural products 
from plants could be interesting alternatives to explore new 
antimicrobial agents.
  Vitex negundo (V. negundo) belonging to the family 
Verbenaceae) is an important medicinal plant found 
throughout Bangladesh, India and some other tropical and 
temperate regions of the world. Even though almost all 
of its parts are used in Ayurvedic and Unani systems of 
medicine, the extracts from its leaves and roots are the most 
important in the field of medicine and drug[10]. Its leaves[11] 
and seeds[12] are widely used externally for rheumatism 
and inflammations of joints and are also reported to have 
insecticidal properties. The antimicrobial activity and 
chemical components of the essential oil isolated from V. 
negundo leaf[13-15] have been reported by several researchers 
in the past. In Bangladesh, leaves of V. negundo are widely 
used for different types of gastroenteritis as traditional 
medicine and it is immensely effective in different types of 
diarrhoea and dysentery. The leaves of V. negundo have been 
reported to possess pesticidal, antifungal and antibacterial 
properties[16]. However very little systemic information of V. 
negundo leaves are available to treat diarrhoeal diseases and 
its activity against enteric pathogenic bacteria. Our aim is 
to examine and evaluate bactericidal activity of V. negundo 
leaves extracts from Bangladesh against diverse multidrug 
resistant enteric pathogens in laboratory conditions as well 
as in animal model experiments.
 
2. Materials and methods
2.1. Collection of medicinal plants and spices
   Leaves of V. negundo were collected  from the Kishoreganj 
district, northern east part of Bangladesh and information 
about their traditional uses for gastroenteritis were collected 
from local people and also verified from two books i) 
Traditional uses of ethnomedicinal plats of Chittagong hill 
tracts published by Bangladesh National Herberium[17] and 
ii) Useful plants of Bangladesh[18].  
2.2. Extraction procedure
  Healthy and well grown V. negundo leaves were collected 
and immediately brought to the laboratory. The leaves were 
first washed with distilled water and then sterilized with 
10% sodium hypochlorite to prevent the contamination of 
any microorganisms. They were then rinsed with distilled 
water again and dried the water. Ten grams of V. negundo 
leaves were cut into small pieces and were grinded to make 
paste with mortar and pestle. Appropriate solvents (water or 
methanol) were added to a concentration of 1 g/10 mL and 
extracted in a soxhlet apparatus for 72 hours. The extracts 
were pooled and the solvent was evaporated using a rotary 
evaporator under reduced pressure at 37 曟. The crude 
extracts were kept at 4 曟 until further use.
2.3. Bacterial strains and culture medium
  Multidrug resistant and drug sensitive enteric pathogens 
used in this study were obtained from our laboratory 
collections. The details of the strains including their 
antibiotic resistance pattern are described in Table 1. All 
strains were grown in Luria broth (LB) broth or on LB agar 
at 37 曟. Bacterial strains were maintained in nutrient 
agar slants at room temperature or in LB broth containing 
15% glycerol at -80 曟. Before use bacterial cultures were 
prepared by inoculating into a tube containing LB and 
Table 1 
List of drug resistant enteric bacterial pathogens examined in this study.
Microorganisms Strain ID Antibiotic resistant pattern Source of isolation
V. cholerae O1 AY-1868921 STR, SXT, NA, ERY, TET Patient
V. cholera O139 NIHCO270 STR, SXT, NA Patient
V. cholera non O1 non O139 2006RV/86 STR, SXT, NA, AMP, KAN, GEN Environmental water
E. coli O157:H7 M-885496 AMP, CHL, SXT, TET Patient
S. dysenteriae Vm110432 CHL Patient
Shigella flexneri M-12163 AMP, TET, CHL Patient
Shigella boydi M-297092 Sensitive Patient
Shigella sonnei M-275521 STR, SXT, NA, ERY, TET Patient
V. parahaemolyticus (O3:K6) pandemic AQ-3794 TETi Patient
V. mimicus MGL-2585 TETi Environmental water
A. sobria MGL-3585/1 NA, AMP Environmental water
Aeromonas cavie MGL-3615/1 AMP Environmental water
i, intermediate resistant; STR, Streptomycin; AMP, ampicillin; TET, tetracycline; NA, nalidixic acid; SXT, Sulphamethoxazole trimethoprime; 
CHL, chloramphenicol; ERY, erythromycin; GEN, gentamicin; KAN, kanamycin.
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subsequent incubation at 37 曟 overnight.  
2.4. Disc diffusion assay
  The test solution was prepared with 10 mg/mL of crude 
extracts, dissolved in 5% dimethyl sulfoxide (DMSO). 
Whatman no.1 sterile filter paper discs (6 mm) were 
impregnated with 10 毺L of the extract to obtain 100 毺g/disc
and allowed to dry at room temperature. Ciprofloxacin (5 毺g/disc)
was used as positive control and 5% DMSO was used as 
negative control. Bacterial growth inhibition was determined 
by standard disc diffusion assay[19]. Briefly, Petri plates 
were prepared by pouring 20 mL of Mueller Hinton agar 
and allowed to solidify. Plates were dried and 100 毺L of 
bacterial suspension containing 1伊106 cells/mL was poured 
in each plate and spread uniformly. The plates were allowed 
to dry for 5 minutes. The filter paper discs impregnated with 
extract (100 毺g/disc) were then placed on the surface of the 
plate. Plates were kept for 2 hours in refrigerator to enable 
pre-diffusion of the extracts into the agar. Then the plates 
were incubated at 37 曟 for 24 h and zone of inhibition was 
observed and measured in millimeters. Reported inhibition 
zones were the average values calculated from at least three 
replicate observations. 
2.5. Determination of minimum inhibitory concentration 
(MIC) and minimum bactericidal concentration (MBC)
  The extract was dissolved in 5% DMSO to obtain 25.6 mg/mL 
and 0.5 mL of stock solution was incorporated into 0.5 mL 
of Mueller Hinton broth to get a concentration of 12 800, 
6 400, 3 200, 1 600, 800, 400, 200, 100 and 50 毺g/mL. Fifty 
microliter of standardized suspension of the test organism 
was transferred onto each tube. MIC of the crude extract 
was then tested in Mueller Hinton broth by broth micro-
dilution method[20]. MBCs were determined by plating 
100 毺L of samples from each MIC assay tube with growth 
inhibition into freshly prepared Mueller Hinton agar plates 
and plates were incubated at 37 曟 for 24 h. The MBC values 
were recorded as the lowest concentration of extract that did 
not permit any visible bacterial colony growth on the agar 
plates during the period of incubation[21]. These assays were 
repeated three times.
 
2.6. Bactericidal activity in vitro
  Bactericidal activity was determined by the viable cell 
count method[22]. Five milliliter of nutrient broth was 
inoculated with the bacterial culture and incubated for 
3 h at 37 曟. Equal volumes of the bacterial suspension 
containing ~1伊106 cells/mL (5 mL) and extract were mixed 
and incubated. At different time intervals viz. 0, 1, 2, 3, 4, 6, 
16 h, 0.2 mL of the mixed suspension was spread on nutrient 
agar plates with different dilutions and were incubated for 
24 h at 37 曟. The mean number of colonies were counted 
and compared with that of the control in which the extract 
was replaced with DMSO. The experiment was repeated three 
times.  
2.7. Laboratory animals
  Swiss albino mice (5-7 days) of either sex used in this 
study were obtained from the Animal resources branch 
of ICDDR, B. The animals were housed in well-ventilated 
and hygienic compartments, maintained under standard 
environmental conditions and fed with standard rodent 
pellet and water ad libitum. All experimental procedures 
were performed according to the NIH Guide for the Care 
and Use of Laboratory Animals. This study was approved by 
the Animal Experimentation Ethics Committee of ICDDR, B 
(institutional).
 2.8. Bacterticidal activity inside mice intestine
  The assay of bactericidal activity of extracts inside mice 
intestine was similar to infant mouse colonization assays and 
were performed with modification of previously described 
method[23]. In brief, batches of 6-day-old infant CD-1 mice 
were inoculated intragastrically with a mixture of overnight 
cultures of V. cholerae strains with different concentrations 
of methanol extracts of V. negundo leaves. The extracts were 
mixed just before feeding of mice. Two control groups one 
was bacteria alone and another was bacteria and DMSO (5%) 
were fed to mice. Six mice were fed in each group. After 
18 h of incubation, the mice were sacrificed, and the small 
intestines were removed and homogenized. The homogenates 
were plated on Luria agar plates, incubated overnight at 
37 曟 and the colonies were counted and compared with the 
controls and initial input. Each experiment was done at least 
on three different groups of mice.
 2.9. Mice survival assay
  The ability of the extracts to protect mice against 
pathogenic V. cholerae infection was determined by 
using groups of ten 5-day old mice with modifications of 
previously described methods[24]. Each mouse was given 
0.05 mL bacterial suspension containing 1伊1010 cfu/mL 
orally and after 1 hr incubation each mouse was given 0.05 
mL of methanol extract of V. negundo leaves. Different 
concentrations of extract were administered to different 
groups of mice. Another control group was given bacteria 
and DMSO. All mice were kept at RT for 18 hrs and then live 
and dead mice were counted and compared with control. 
The experiments were done with three different groups of 
mice for each sample.
  The mean values and the standard deviations were 
calculated from the data obtained with three separate 
experiments. The data on percentage of mice survival 
were statistically analyzed by using Student’s t test for 
the significance, and a P value < 0.05 was considered 
statistically significant.
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3. Results
3.1. Antibacterial activity of V. negundo leaf extract
  Antibacterial activity for both methanol and water extracts 
of V. negundo leaves were examined against diverse enteric 
pathogens and most of them were resistant against one 
or more antimicrobial drugs (Table 1). Methanol extract 
exhibited potent antibacterial activity against V. cholerae 
O1, O139, non O1 non O139 strains; E. coli O157:H7 strain; 
Vibrio parahaemolyticus (V. parahaemolyticus) O3:K6 
pandemic strain, and Aeromonas species (Table 2). The zone of 
inhibition ranged between (15.233暲0.351) and (22.600暲0.818) 
mm for above strains against 100 毺g of extract. Moderate 
antibacterial activity was observed for other enteric 
pathogens tested (Table 2) and the zone of inhibition ranged 
between (9.966暲0.702) and (13.466暲0.288) mm. The water 
extract of V. negundo leaves showed moderate antibacterial 
activity against V. cholerae strains and V. parahaemolyticus 
strain only (Table 2). 
3.2. MIC and MBC of methanol extract of V. negundo leaves
   Between methanol extract and water extract of V. negundo 
leaves, methanol extract showed potent antibacterial 
activity against different enteric pathogens. Hence, we 
determined the MIC and MBC of methanol extract against 
different enteric pathogens. MIC value indicates the lowest 
concentration of the extract that exhibits the growth 
inhibition of particular bacteria and MBC value indicates the 
lowest concentration that can kill any particular organism. 
MIC value of the methanol extract of V. negundo leaf was 
200 毺g/mL for pathogenic Vibrio species and Aeromonas 
sobria (A. sobria), 800 毺g/mL for Vibrio mimicus (V. mimicus) 
and all types of Shigella spp. except Shigella dysenteriae (S. 
dysenteriae), 1 600 毺g/mL for pathogenic E. coli. The high MIC 
value was observed for S. dysenteriae strain (3 200 毺g/mL). 
MBC value of V. negundo methanol extract was higher than 
the MIC. The MBC was 200 毺g/mL for V. cholerae non O1 
non O139 strains and for A. sobria strain, 400 毺g/mL for V. 
cholerae O1, O139 strains and V. parahaemolyticus strain, 
800 毺g/mL for V. mimicus, different Shigella spps. except S. 
dysenteriae, 1 600 毺g/mL for pathogenic E. coli strain.
3.3. Bactericidal activity of V. negundo leaves methanol 
extract in vitro
   Since we found that methanol extract of V. negundo leaves 
showed potent bacterial killing activity, we examined the 
bactericidal activity of methanol extract against different 
enteric pathogens at different time intervals by using viable 
bacterial count methods under laboratory conditions. We 
used 500 毺g/mL of methanol extract of V. negundo leaves, 
as this is the moderate concentration that can kill bacteria 
found from MBC results. The 500 毺g/mL methanol extract 
of V. negundo leaves exhibited strong bactericidal activity 
Table 2
Antibacterial activity of methanol extract and water extract of V. negundo leaf against pathogenic enteric bacterial strains (mean暲SD).
Microorganisms
Mean zone of inhibition (mm)
Water extract (100 毺g/disc) Methanol extract (100 毺g/disc) Ciprofloxacin (5 毺g/disc)
V. cholerae O1 10.033暲0.404 21.133暲0.503 33.833暲0.416
V. cholera O139   9.466暲0.665 19.700暲0.529 32.166暲0.832
V. cholera non O1 non O139 10.500暲0.200 22.600暲0.818 35.433暲0.585
E. coli O157:H7 no zone 15.233暲0.351 28.900暲0.400
S. dysenteriae no zone 10.566暲0.568 28.033暲0.808
Shigella flexneri no zone 12.066暲0.568 30.266暲0.208
Shigella boydi no zone 11.733暲0.723 31.933暲0.611
Shigella sonnei no zone 13.466暲0.288 29.033暲0.305
V. parahaemolyticus (O3:K6) pandemic 10.133暲0.251 18.466暲0.472 34.633暲0.642
V. mimicus no zone   9.966暲0.702 34.733暲0.642
A. sobria no zone 16.700暲0.435 32.266暲0.737
Aeromonas cavie no zone 17.733暲0.568 33.100暲0.173
Table 3
Bactericidal activity of V. negundo leaf methanol extract (500 毺g/mL) against different enteropathogenic bacterial strains in in vitro conditions.
Strains
Viable bacterial counts (cfu/mL) at different time intervals
Inoculums 1 h 2 h 3 h 4 h 6 h 16 h
V. cholerae O1 1.2伊107 0 0 0 0 0 0
V. cholerae  O139 2.2伊107 1.8伊103 0 0 0 0 0
V. cholerae non O1 non O139 7.8伊106 0 0 0 0 0 0
V. parahaemolyticus O3:K6 9.8伊106 0 0 0 0 0 0
E. coli O157:H7 7.9伊106 7.4伊106 6.3伊106 2.1伊106 5.4伊105 1.2伊105 8.6伊104
S. dysenteriae 8.6伊106 7.9伊106 7.2伊106 6.1伊106 3.4伊106 9.7伊105 5.4伊105
V. mimicus 4.3伊106 3.7伊105 3.1伊105 2.7伊104 1.3伊104 9.5伊103 9.0伊103
A. sobria 7.2伊106 0 0 0 0 0 0
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against different enteric pathogens and this concentration 
was able to completely kill pathogenic V. cholera of different 
serotypes, V. parahaemolyticus, and A. sobria strains and 
were unable to kill E. coli O157:H7, S. dysenteriae and V. 
mimicus strains up to 16 hrs incubation period (Table 3). 
However, this concentration showed bacteriostatic activity 
against those strains.
3.4. Bactericidal activity of V. negundo leaf methanol extract 
in in vivo
  The MBC value and in vitro bactericidal activity study 
clearly indicated that methanol extract of V. negundo 
leaves had potent antibacterial activity against Vibrio 
species, especially against all types of pathogenic V. 
cholerae strains. Therefore, these results convinced us to 
examine the bactericidal activity of these extracts in in vivo 
conditions. V. cholerae is a major causative agent of the 
devastating diarrhoeal disease cholera and these bacteria 
were able to colonize the infant mice intestine. Here we 
examined the ability of this extract to kill the bacteria in 
the mice intestinal environment. In this experiment we 
used pathogenic strains of V. cholerae O1 El Tor; O139; 
and non O1 non O139 strains. We administered ~1伊108 live 
bacterial cells along with different concentrations of V. 
negundo leaves methanol extract and found that 2.0 mg/mL
concentration of V. negundo leaf methanol extract killed all 
types of V. cholerae inside the mice intestinal environment 
and therefore we could not retrieve any viable bacteria 
from the homogenized mice intestine, whereas, 1.0 mg/mL
concentration was enough to kill non O1 non O139 strain 
completely (Table 4). These results indicated that the 
active compound of V. negundo leaf which has bactericidal 
activity in vitro was found to retain the activity under in vivo 
conditions as well. 
Table 4 
Vibriocidal activity of V. negundo leaf methanol extract against 
different V. cholerae strains in mice intestinal environment.
Strains
Inoculums
(cfu/mL)
V. negundo methanol extract   
(mg/mL)
0.5 1.0 2.0 3.0
V. cholerae O1 1.8伊108 6.0伊104 1.2伊102 0 0
V. cholerae O139 8.2伊107 1.2伊103 2.2伊102 0 0
V. cholerae 
non O1 non O139
2.3伊108 3.4伊103 0 0 0
3.5. V. negundo leaf extract can protect mice against V. 
cholerae infection
   Pathogenic V. cholerae induce the mortality in infant 
mice[24]. Here we examined the ability of the V. negundo leaf 
methanol extract to protect mice challenged with a high dose 
of pathogenic V. cholerae. Mice have been used as a model 
for V. cholerae pathogenesis in which mice are ultimately 
killed by the bacteria. When we orally administered V. 
cholerae strains and then administered DMSO (5%) as control 
we observed that about 80% of mice died after 18 h of 
incubation. Whereas when we first administered cholera 
bacteria and then administered different concentrations 
of V. negundo leaf methanol extract, we found that the 
extracts had the ability to protect mice and increased their 
survival rate in a dose dependent manner (Figure 1). The 2 
mg/mL and 3 mg/mL of V. negundo leaf methanol extract 
significantly increased (P<0.001 and P<0.000 1) the survival 
rate up to 60% and 80% of mice respectively. On the other 
hand high mortality of mice was observed when 10 mg/mL of 
extract was used, suggesting that the higher dose might toxic 
to mice.
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Figure 1. Effects of V. negundo leaf methanol extract on mice survival 
against V. cholerae infection.
4. Discussion
   During the second half of the 20th century, the acceptance 
of traditional medicine as an alternative form of health care 
and the development of microbial resistance to the available 
antibiotics led researchers to investigate the antimicrobial 
activity of medicinal plants.
  In this study, we collected the V. negundo leaves from 
the north-east part of Bangladesh, where it is readily 
used to treat diarrhoea, dysentery and different types of 
gestroenteritidis. We examined the antibacterial activity 
of both methanol and water extracts against different drug 
sensitive and multi drug resistant pathogenic bacteria 
isolated from clinical and environmental sources. These 
bacteria are major causative agents of different kinds of 
enteric diseases. The extracts were examined for their 
antibacterial activity against various types of V. cholerae 
epidemic strains, V. parahaemolyticus O3:K6 pandemic 
strain, E. coli O157:H7 strain, different types of Shigella 
strains, toxigenic V. mimicus strain and strains of 
Aeromonas spps. 
  Toxigenic strains of V. cholerae belonging to the O1 and 
O139 serogroups cause cholera, a severe diarrheal disease 
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that occurs frequently as epidemics in many developing 
countries[25]. Strains belonging to other serogroups, 
collectively referred to as non-O1, non-139, have also been 
implicated as etiologic agents of moderate to severe human 
gastroenteritis[26,27]. V. mimicus has also been implicated in 
diarrheal disease, and some strains of V. mimicus have been 
demonstrated to carry virulence genes including cholera 
toxin gene and produce cholera toxin[27-29]. Pathogenic V. 
parahaemolyticus cause gastroenteritis through consumption 
of sea foods. Pandemic strains of V. parahaemolyticus mainly 
O3:K6 clone first emerged in Asia in 1995 and then rapidly 
spreads and causes outbreaks in north and south America, 
Europe and Africa[30-32]. Enterohaemorrhagic E. coli (EHEC) 
O157:H7 is a human pathogen that contributes to an average 
of 17 outbreaks and 75 000 cases of illness each year in 
the USA alone[33]. EHEC O157:H7 strains cause a range of 
clinical complications including diarrhoea, haemorrhagic 
colitis and haemolytic uraemic syndrome[34,35]. The largest 
outbreak caused by E. coli O157:H7 in 1996 in Sakai, 
Japan[36]. Bacillary dysentery caused by Shigella species is 
a public health problem in developing countries including 
Bangladesh. Shigellosis occurs as a disease endemic in 
Bangladesh, and at least three large epidemics caused 
by S. dysenteriae type 1 have occurred between 1972 and 
1994, causing high morbidity and mortality, particularly in 
children[37,38].
  V. negundo is a very well known medicinal plant for its 
wide range of uses traditionally. Almost all of its parts 
are used in Ayurvedic and Unani systems of medicine[10] 
and V. negundo leaf extracts had been reported to possess 
antibacterial, antifungal, pesticidal activity[13,39-42]. It also 
has antioxidant and anti-inflamatory and hepatoprotective 
activity[43-49]. However, effects of V. negundo leaf extracts 
on enteric pathogens are not well studied. In different parts 
of Bangladesh, V. negundo leaves are traditionally used for 
different types of gastroenteritis, fever, hyper acidity and 
leismoniasis[18].
  We examined the methanol and water extract of V. negundo 
leaf by disc diffusion assay and found that methanol extract 
of V. negundo showed moderate to strong antibacterial 
activity against all types of enteric pathogens tested and 
exhibited very potent antibacterial activity against all types 
of V. cholerae strains, the major causative agent of cholera. 
The antibacterial activity of V. negundo leaf methanol 
extract was previously examined against other bacterial 
specieses[13,15,44]. 
  As methanol extract exhibited potent antibacterial 
activity than water extract, we used methanol extract of V. 
negundo leaf for further experiments in this study. Methanol 
was widely used as a solvent to prepare medicinal plant 
extracts[50,51] and this is the solvent, well known for its nature 
to dissolve wide range of antimicrobials including tannins, 
polyphenols, terpenoids, saponins, lactones, flavones and 
phenones[7]. 
  Since disc diffusion assay has some limitations and 
this assay only indicate the growth inhibition ability of 
the extracts against certain microorganisms, it could 
not tell whether the inhibition zone is for bactericidal or 
bacteriostatic activity of the certain extracts. Therefore, 
to confirm the nature of activity and specific dose against 
certain microorganisms, we determined the MIC and MBC of 
the extracts and found that MIC value was within the range of 
200-800 毺g/mL for all enteric bacteria tested except E. coli 
O157:H7 and S. dysenteriae. From MBC value it was found 
that methanol extract of V. negundo leaf could kill all types 
of enteric bacteria tested but different doses were needed for 
different bacteria. A range of 200-400 毺g/mL of the extract 
was sufficient to kill the V. cholerae, V. parahaemolyticus 
and A. sobria strains. Hence, our data suggested that V. 
negundo leaf methanol extract has both growth inhibition 
as well as killing activity against all the bacteria tested and 
those activity is very potent on V. cholerae O1, O139, non 
O1 non O139 strains, V. parahaemolyticus pandemic strain, 
toxigenic V. mimicus and Aeromonas spps. 
  In vitro bactericidal activity of V. negundo leaf methanol 
extract (500 毺g/mL) at different time interval suggested 
that it has very strong killing activity against all the Vibrio 
species and Aeromonas spps. tested and interestingly within 
one hour incubation period this extract was able to killed all 
the bacterial cells (~1伊106 cfu/mL) incubated with the extract 
whereas this concentration of extract (500 毺g/mL) was not 
able to kill E. coli O157:H7, S. dysenteriae and V. mimicus 
strains. However, this concentration can inhibit the growth 
of these microorganisms and act as potent bacteriostatic 
agent at lower dose. The microorganisms we examined in 
this study are Gram-negative bacteria. It was suggested that 
the lipopolysaccharides present in the outer membrane of 
Gram-negative bacteria gave them more resistance towards 
antibacterial agents than Gram-positive bacteria[52,53]. 
Nevertheless, we demonstrated here potent antibacterial 
activity of V. negundo leaf methanol extract against number 
of Gram-negative enteric pathogens.
  As V. negundo leaf methanol extract exhibited bactericidal 
activity, especially on V. cholerae, which is called vibriocidal 
activity, in vitro, this result prompted us to examine the 
vibriocidal activity of this extract in in vivo conditions. V. 
cholerae can colonize in mice intestine and help to express 
virulence determinents and ultimately cause disease. 
Here 5-day old mice were administered high dose (~1伊108 
cfu/mL) of viable V. cholerae cells with different dose of V. 
negundo leaf methanol extracts (0.5 mm/mL to 10 mg/mL), 
as we do not know which dose will be able to kill bacteria 
inside mice intestinal environments. Very surprisingly 
we found that V. negundo leaf methanol extract was able 
to retain its activity in intestinal conditions and 2 mg/mL
of concentrations were completely killed all the V. cholerae 
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bacteria administered whereas 1 mg/mL of extract was able 
to killed all the cells of V. cholerae non O1 non O139 strain. 
These results suggested that the compounds of V. negundo 
leaf responsible for antibacterial activity in vitro are effective 
to exert its activity in vivo also. This result convinced us 
to examine the potentiality of this extract whether it can 
be able to protect mice from the pathogenic V. cholerae 
infection.
  Pathogenic V. cholerae can cause death of infant mice in 
cholera model experiments[24], therefore we administered 
the mice with high dose of pathogenic V. cholerae O1 
strain orally and then challenged with different doses of V. 
negundo leaf methanolic extract to observe whether this 
extract can protect the mice from the disease and reduce 
the mortality rate. Here we also got motivating results that 
V. negundo leaf extract significantly induced the survival 
rate (P<0.001 and P<0.000 1) of the mice in dose dependent 
manner and 3 mg/mL concentration was able to increase 
the survival rate up to 80%, whereas only 20% of mice were 
survived by bacteria without extract. 
  In this study, we have shown the antibacterial activity of V. 
negundo leaf extracts on a wide range of enteric pathogens 
eg., V. cholerae, V. parahaemolyticus, V. mimicus, E. coli, 
Shigella species and Aeromonas species. These organisms 
can cause severe diarrhoeal diseases and dysentery. Here 
for the first time we also carried out in vivo assay with 
extracts  in mice cholera model and evidenced that V. 
negundo leaf methanol extract is equally potent both in vitro 
and in vivo conditions to kill the cholera causing bacteria 
and protect mice from disease and death. If we identified 
and isolate the active compounds from V. negundo leaf, 
responsible for vibriocidal acitivity in vivo, then it could be 
a good alternative of antibiotics to treat cholera to reduce 
the disease burden. Therefore, further studies should be 
undertaken to characterize the active compounds residing 
in V. negundo leaves. Additionally, evaluation of the effects 
of each individual compound on microorganisms as well as 
toxicological studies need to be performed.
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